RCUS vs WELL · rev $258.0M vs P/E 100, rev $10.84B
Arcus Biosciences Inc (RCUS) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
RCUS currently screens at market cap $885.2M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the RCUS and WELL stock pages for the full models.
Not investment advice.